Top

Gepubliceerd in:

01-12-2002 | Artikelen

Risicofactoren voor dementie en achteruitgang in cognitieve functies

Auteurs: Mirjam Geerlings, Sandra Kalmijn

Gepubliceerd in: Neuropraxis | Uitgave 6/2002

Samenvatting

Dementie is een klinisch syndroom met een progressief ziektebeloop. Om tot de diagnose dementie te komen moeten er, per definitie, ernstige geheugenstoornissen aanwezig zijn en stoornissen in andere cognitieve functies, zoals afasie, apraxie, agnosie, of stoornissen in de uitvoerende functies. De cognitieve stoornissen moeten zodanig zijn dat zij duidelijk het sociaal of beroepsmatig functioneren beperken, vooral ten opzichte van het vroegere functioneren. Doordat veel ouderen enige mate van achteruitgang in het geheugen en andere cognitieve functies hebben, is het onderscheid tussen normale en pathologische cognitieve achteruitgang moeilijk te maken. In deze bijdrage zullen wij ons vooral richten op risicofactoren voor dementie, en in sommige gevallen ook op cognitieve achteruitgang, met de assumptie dat dit een voorstadium van dementie betreft.

vorige artikel Cognitieve achteruitgang bij ouderen. De bijdrage van erfelijkheid, gezondheid en leefstijl

volgende artikel Veroudering vraagt om verrijking

Aronson M.K., W.L. Ooi, H. Morgenstern, A. Hafner, D. Masur, H. Crystal et al. (1990).Women, myocardial infarction, and dementia in the very old. Neurology 40:1102-1106.

Bassuk S.S., L.F. Berkman & D. Wypij (1998). Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch Gen Psychiatry 55:1073-1081.

Breteler M.M. (2000). Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 21:153-160.

Chen P., M. Ganguli, B.H. Mulsant & S.T. DeKosky (1999). The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 56:261-266.

Christen Y. (2000). Oxidative stress and Alzheimer disease. Am J Clin Nutr 71:621S-629S.

Cruts M. & C. van Broeckhoven (1998). Molecular genetics of Alzheimer's disease. Ann Med 30:560-565.

Das U.N. (2002). Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link? Nutrition 18:178-188.

Devanand D.P., M. Sano, M.X. Tang, S. Taylor, B.J. Gurland, D. Wilder et al. (1996). Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 53:175-182.

Engelhart M.J., M.I. Geerlings, A. Ruitenberg, J.C. van Swieten, A. Hofman, J.C. Witteman et al. (2002). Dietary intake of antioxidants and risk of Alzheimer disease. jama 287:3223-3229.

Engelhart M.J. (2002). aangeboden.

Fabrigoule C., L. Letenneur, J.F. Dartigues, M. Zarrouk, D. Commenges & P. Barberger-Gateau (1995). Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc 43:485-490.

Geerlings M.I., B. Schmand, C. Jonker, J. Lindeboom, L.M. Bouter (1999). Education and incident Alzheimer's disease: a biased association due to selective attrition and use of a two-step diagnostic procedure? Int J Epidemiol 28:492-497.

Geerlings M.I., R.A. Schoevers, A.T. Beekman, C. Jonker, D.J. Deeg, B. Schmand et al. (2000). Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry 176:568-575.

Geerlings M.I., A. Ruitenberg, J.C. Witteman, J.C. van Swieten, A. Hofman, C.M. van Duijn et al. (2001). Reproductive period and risk of dementia in postmenopausal women. jama 285:1475-1481.

Haan M.N., L. Shemanski, W.J. Jagust, T.A. Manolio & L. Kuller (1999). The role of apoe epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. jama282:40-46.

Henderson V.W., A. Paganini-Hill, B.L. Miller, R.J. Elble, P.F. Reyes, D. Shoupe et al. (2000). Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54:295-301.

Hofman A., A. Ott, M.M. Breteler, M.L. Bots, A.J. Slooter, F. van Harskamp et al. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349:151-154.

In ’t Veld B.A., A. Ruitenberg, A. Hofman, L.J. Launer, C.M. van Duijn, T. Stijnen et al. (2001). Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345:1515-1521.

Kalmijn S., E.J. Feskens, L.J. Launer & D. Kromhout (1996). Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996; 27:2230-2235.

Kalmijn S., L.J. Launer, A. Ott, J.C. Witteman, A. Hofman & M.M. Breteler (1997a). Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42:776-782.

Kalmijn S., E.J. Feskens, L.J. Launer & D. Kromhout (1997b). Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 145:33-41.

Kalmijn S., L.J. Launer, J. Lindemans, M.L. Bots, A. Hofman & M.M. Breteler (1999). Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 150:283-289.

Kalmijn S., K.M. Mehta, H.A. Pols, A. Hofman, H.A. Drexhage & M.M. Breteler (2000). Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 53:733-737.

Kukull W.A. (2001). The association between smoking and Alzheimer's disease: effects of study design and bias. Biol Psychiatry 49:194-199.

Launer L.J., K. Andersen, M.E. Dewey, L. Letenneur, A. Ott, L.A. Amaducci et al. (1999). Rates and risk factors for dementia and Alzheimer's disease: results from eurodem pooled analyses. eurodem Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 52:78-84.

Launer L.J. (2000). Is there epidemiologic evidence that anti-oxidants protect against disorders in cognitive function? J Nutr Health Aging 4:197-201.

Launer L.J., G.W. Ross, H. Petrovitch, K. Masaki, D. Foley, L.R. White et al. (2000). Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21:49-55.

Laurin D., R. Verreault, J. Lindsay, K. MacPherson & K. Rockwood (2001). Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58:498-504.

Letenneur L., L.J. Launer, K. Andersen, M.E. Dewey, A. Ott, J.R. Copeland et al. (2000). Education and the risk for Alzheimer's disease: sex makes a difference. eurodem pooled analyses. eurodem Incidence Research Group. Am J Epidemiol 151:1064-1071.

Lobo A., L.J. Launer, L. Fratiglioni, K. Andersen, A. Di Carlo, M.M. Breteler et al. (2000). Prevalence of dementia and major subtypes in Europe:A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54:S4-S9.

Merchant C., M.X. Tang, S. Albert, J. Manly, Y. Stern & R. Mayeux (1999). The influence of smoking on the risk of Alzheimer's disease. Neurology 52:1408-1412.

Morris M.C., D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal et al. (2002). Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. jama 287:3230-3237.

Muldoon M.F., S.D. Barger, C.M. Ryan, J.D. Flory, J.P. Lehoczky, K.A. Matthews et al. (2000). Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000; 108(7):538-546.

Mulnard R.A., C.W. Cotman, C. Kawas, C.H. van Dyck, M. Sano, R. Doody et al. (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. jama 283:1007-1015.

Ott A., R.P. Stolk, A. Hofman, F. van Harskamp, D.E. Grobbee & M.M. Breteler (1996). Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39:1392-1397.

Ott A., A.J. Slooter, A. Hofman, F. van Harskamp, J.C. Witteman, C. van Broeckhoven et al. (1998). Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 351:1840-1843.

Peila R., B.L. Rodriguez & L.J. Launer. (2002). Type 2 diabetes, apoe gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51:1256-1262.

Ruitenberg A., A. Ott, J.C. van Swieten, A. Hofman & M.M. Breteler (2001). Incidence of dementia: does gender make a difference? Neurobiol Aging 22:575-580.

Ruitenberg A., I. Skoog, A. Ott, O. Aevarsson, J.C. Witteman, B. Lernfelt et al. (2001). Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 12:33-39.

Ruitenberg A., J.C. van Swieten, J.C. Witteman, K.M. Mehta, C.M. van Duijn, A. Hofman et al. (2002). Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 359:281-286.

Sano M., C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman et al. (1997). A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336:1216-1222.

Sapolsky R.M., L.C. Krey & B.S. McEwen (1986). The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284-301.

Sapolsky R.M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925-35.

Scarmeas N., G. Levy, M.X. Tang, J. Manly & Y. Stern (2001). Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 57:2236-2242.

Scott H.D. & K. Laake K. (2001). Statins for the reduction of risk of Alzheimer's disease. Cochrane Database Syst Rev (3):CD003160.

Seshadri S., A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, R.B. d'Agostino et al. (2002).Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476-483.

Skoog I., B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, L. Nilsson (1996). et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145.

Snowdon D.A., L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner & W.R. Markesbery (1997). Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. jama 277:813-817.

Schmidt R., H. Schmidt, J.D. Curb, K. Masaki, L.R. White & L.J. Launer (2002). Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52:168-74.

Sorbi S., P. Forleo, A. Tedde, E. Cellini, M. Ciantelli, S. Bagnoli et al. (2001). Genetic risk factors in familial Alzheimer's disease. Mech Ageing Dev 122:1951-1960.

Stern Y., B. Gurland, T.K. Tatemichi, M.X. Tang, D. Wilder & R. Mayeux (1994). Influence of education and occupation on the incidence of Alzheimer's disease. jama 271:1004-1010.

Stern Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448-460.

Tang M.X., D. Jacobs, Y. Stern, K. Marder, P. Schofield, B. Gurland et al. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432.

Volpato S., J.M. Guralnik, L.P. Fried, A.T. Remaley, A.R. Cappola & L.J. Launer (2002). Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 58:1055-1061.

Wang H.X., A. Karp, B. Winblad & L. Fratiglioni (2002). Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the kungsholmen project. Am J Epidemiol 155:1081-1087.

Wolozin B., W. Kellman, P. Ruosseau, G.G. Celesia & G. Siegel (2000). Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439-1443.

Yaffe K., D. Barnes, M. Nevitt, L.Y. Lui & K. Covinsky (2002). A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 161:1703-1708.

Yaffe K., T. Blackwell, R. Gore, L. Sands, V. Reus & W.S. Browner (1999). Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry 56:425-430.

Yaffe K., G. Sawaya, I. Lieberburg & D. Grady (1998). Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. jama 279:688-695.

Yoshitake T., Y. Kiyohara, I. Kato, T. Ohmura, H. Iwamoto, K. Nakayama et al. (1995). Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45:1161-1168.

Titel: Risicofactoren voor dementie en achteruitgang in cognitieve functies
Auteurs: Mirjam Geerlings
Sandra Kalmijn
Publicatiedatum: 01-12-2002
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Neuropraxis / Uitgave 6/2002
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI: https://doi.org/10.1007/BF03071034

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2002

Met of zonder ziende ogen oud worden. Is er keus?

Ouderen: een opwindende doelgroep voor de neurowetenschappen

Veroudering vraagt om verrijking

Cognitieve achteruitgang bij ouderen. De bijdrage van erfelijkheid, gezondheid en leefstijl

Veroudering van het evenwichtsorgaan

Hoe en waarom wij oud worden